Literature DB >> 10519993

Role of FcgammaRI (CD64) in erythrocyte elimination and its up-regulation in thalassaemia.

E Wiener1, D Allen, R J Porter, S N Wickramasinghe, J B Porter, S Chinprasertsuk, U Siripanyaphinyo, K Pattanapanyasat, S Fucharoen, W Wanachiwanawin.   

Abstract

To examine any role of the high affinity Fcgamma class I receptor (FcgammaRI) (CD64) in erythrocyte elimination by mononuclear phagocytes (MP) in thalassaemia (thal), we investigated the in vitro interaction of beta-thalassaemic erythrocytes with monocytes (Mo) whose FcgammaR expression had been modulated by cytokines. Treatment of Mo with interferon (IFN)-gamma or interleukin (IL)-10 which up-regulate FcgammaRI, caused a dose-dependent increase in binding of beta-thalassaemic erythrocytes, whereas stimulation with IL-4 which down-regulates the receptor, reduced this interaction, in a dose-dependent manner, to that of normal erythrocytes. Binding of thalassaemic erythrocytes by IFN-gamma or IL-10-treated Mo was inhibited by FcgammaRI-specific reagents. In addition, Mo expression of FcgammaRI and HLA class II DR was determined by flow cytometry in Thai patients with HbH disease (alpha1/alpha2 or alpha1/Hb Constant Spring) (n = 15) or beta degrees -thal/HbE (n = 16). In both groups of patients FcgammaRI expression was increased as compared to normal controls (n = 14): mean fluorescence intensity (+/-SD) 124.79 +/- 38. 77 in HbH disease and 121.86 +/- 18.23 in beta degrees -thal/HbE versus 91.94 +/- 17.36 in normal controls (P < 0.01 and P < 0.001, respectively). In contrast, HLA class II DR expression was similar in patients and controls. The results suggest that, in thalassaemia, up-regulated FcgammaRI on mononuclear phagocytes plays a role in their interaction with erythrocytes and that this process can be modified by cytokines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519993     DOI: 10.1046/j.1365-2141.1999.01646.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  MiR-155 enhances phagocytic activity of β-thalassemia/HbE monocytes via targeting of BACH1.

Authors:  Kanitta Srinoun; Chamnong Nopparatana; Malai Wongchanchailert; Suthat Fucharoen
Journal:  Int J Hematol       Date:  2017-07-06       Impact factor: 2.490

2.  FcγRI (CD64): an identity card for intestinal macrophages.

Authors:  Jaime De Calisto; Eduardo J Villablanca; J Rodrigo Mora
Journal:  Eur J Immunol       Date:  2012-12       Impact factor: 5.532

3.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.